MYP_152647
Basic Information
Efgartigimod alfa
Immunology Immune modulation Immunomodulatory activity
Therapeutic / Biomedical activity Enzyme replacement therapy
Standard
227 amino acids
C1155H1783N301O346S7
Standard
Sequence
DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLYITREPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALKFHYTQKSLSLSPGK
Physicochemical Analysis
25645.78 Da
7.14
0.25
-0.42
0.0011
-0.60
0.48
-0.05
42.93
70.26
0.0969
36900.00
37275.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0207246 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
cyclic peptide scaffold [Cyclic]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Immunomodulatory Enzyme replacement
CHO
The terminal elimination half-life of efgartigimod alfa ranges from 80 to 120 hours.[L39496]